XPH(SZ:300147) Feng Huang Wang Cai Jing·2025-09-24 09:30Group 1 - The forum "Phoenix Bay Area Finance Forum 2025" was held in Guangzhou, focusing on the theme "New Pattern, New Path" and gathering global political, business, and academic elites to explore development opportunities [1] Group 2 - The chairman of Guangzhou Xiangxue Pharmaceutical Co., Ltd., Wang Yonghui, emphasized the revolutionary opportunities that artificial intelligence (AI) and big data technologies bring to the development of traditional Chinese medicine (TCM), promoting its scientific and international progress [3] - Wang pointed out that TCM is fundamentally a data science, but the traditional reliance on individual experiences of renowned doctors has limitations such as insufficient data volume and unstable effects, making it difficult to undergo scientific validation [3] - He noted that the long-standing transmission of TCM has been constrained by human contact, lifespan, and experience, with the current era of big data and AI capable of addressing these shortcomings [3] - Wang believes that TCM is an ideal application scenario for AI, as technological innovations provide strong support for the personalized diagnosis and treatment advantages of TCM [4] - He explained that large models align well with the dialectical logic of TCM, processing knowledge from vast data to holistic models, allowing for reasoning that captures non-linear associations [3] - The output from these models is dynamic and personalized, resulting in "fuzzy correctness" rather than purely logical data relationships [3] Group 3 - Through AI empowerment, TCM is breaking through the limitations of experiential "black box" phenomena, achieving precision and intelligence in diagnosis and treatment, ultimately leading to significant improvements in therapeutic effects and continuous evolution [4] - Wang expressed confidence that as therapeutic effects continue to improve, TCM will gain widespread recognition globally and shine in the field of human health [4]